RUNX1T1 and leukemia: Most of these are recurrent and class-defining in pAML (e.g., KMT2Ar: 20.2%, RUNX1::RUNX1T1: 12.3%, Fig.1B, Fig.1E, Table.S6), whereas we also found fusions recurrent in other leukemias, such as SET::NUP21427 (n=1) or SFPQ::ZFP36L228 (n=1).